| Indicators | Browse All

GRAIL, Inc. (GRAL)

Healthcare | Diagnostics & Research | Menlo Park, United States | NasdaqGS
80.00 USD -2.50 (-3.030%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 80.00

Short-term:★★★☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 1:36 a.m. EDT

The legal overhang is the primary constraint on this investment thesis, with a fraud lawsuit and class action deadline casting a shadow over the business. While the company is generating strong revenue growth of roughly 26 percent and holds a net cash position, the lack of profitability and negative cash flow create a precarious financial picture. Technically, the stock has recovered above its key moving averages, offering a short-term bounce, but the analyst consensus targets remain below the current price. Options activity suggests traders are hedging against a drop while hoping for a breakout, reflecting the polarized sentiment. For a long-term hold, the legal risks and earnings deficits outweigh the growth story, making this a neutral-to-cautious position rather than a clear buy.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.080482
AutoARIMA0.083927
AutoETS0.083928
AutoTheta0.125019

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 35%
H-stat 0.10
Ljung-Box p 0.000
Jarque-Bera p 0.213
Excess Kurtosis -1.24
Attribute Value
Sector Healthcare
Debt to Equity Ratio 3.591
Revenue per Share 4.114
Market Cap 3,573,298,688
Forward P/E -8.11
Beta 3.25
Profit Margins -236.95%
Previous Name GRAIL, LLC
Website https://grail.com

As of Aug. 22, 2026, 1:36 a.m. EDT: Speculators are positioning for a range-bound outcome with heavy downside protection at the 55 to 60 strike levels for the near term, while call buyers are targeting a breakout above the 80 level. Implied volatility remains elevated across all expirations, indicating significant uncertainty about the path ahead.


Info Dump

Attribute Value
52 Week Change 1.6099336
Address1 1,525 O’Brien Drive
All Time High 118.84
All Time Low 12.33
Ask 80.09
Ask Size 1
Audit Risk 2
Average Analyst Rating 2.1 - Buy
Average Daily Volume10 Day 697,310
Average Daily Volume3 Month 704,324
Average Volume 704,324
Average Volume10Days 697,310
Beta 3.246
Bid 57.66
Bid Size 2
Board Risk 6
Book Value 56.926
City Menlo Park
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 9
Country United States
Crypto Tradeable 0
Currency USD
Current Price 80.0
Current Ratio 10.949
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 80.9899
Day Low 77.7
Debt To Equity 3.591
Display Name GRAIL
Earnings Call Timestamp End 1,785,961,800
Earnings Call Timestamp Start 1,785,961,800
Earnings Timestamp 1,785,960,000
Earnings Timestamp End 1,794,427,200
Earnings Timestamp Start 1,794,427,200
Ebitda -378,488,992
Ebitda Margins -2.29022
Enterprise To Ebitda -7.701
Enterprise To Revenue 17.637
Enterprise Value 2,914,664,192
Eps Current Year -7.675
Eps Forward -9.87
Eps Trailing Twelve Months -9.4
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 70.4122
Fifty Day Average Change 9.587799
Fifty Day Average Change Percent 0.13616672
Fifty Two Week Change Percent 160.99336
Fifty Two Week High 118.84
Fifty Two Week High Change -38.839996
Fifty Two Week High Change Percent -0.32682598
Fifty Two Week Low 30.82
Fifty Two Week Low Change 49.18
Fifty Two Week Low Change Percent 1.5957171
Fifty Two Week Range 30.82 - 118.84
Financial Currency USD
First Trade Date Milliseconds 1,718,199,000,000
Float Shares 34,289,821
Forward Eps -9.87
Forward P E -8.10537
Free Cashflow -103,579,128
Full Exchange Name NasdaqGS
Full Time Employees 910
Fullday Change -2.5
Fullday Change Percent -3.0303
Fullday Price 80.0
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,785,542,400
Gross Margins 0.49707
Gross Profits 82,147,000
Has Pre Post Market Data 1
Held Percent Insiders 0.050240003
Held Percent Institutions 0.86791
Implied Shares Outstanding 44,666,234
Industry Diagnostics & Research
Industry Disp Diagnostics & Research
Industry Key diagnostics-research
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Long Name GRAIL, Inc.
Market us_market
Market Cap 3,573,298,688
Market State CLOSED
Max Age 86,400
Message Board Id finmb_321823804
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-08-28
Net Income To Common -391,587,008
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 3,684,964,305
Number Of Analyst Opinions 8
Open 80.131
Operating Cashflow -294,748,992
Operating Margins -3.31998
Overall Risk 7
Payout Ratio 0.0
Phone 833 694 2553
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 80.0
Post Market Time 1,787,959,806
Prev Name GRAIL, LLC
Previous Close 82.5
Price Eps Current Year -10.423452
Price Hint 2
Price To Book 1.4053333
Price To Sales Trailing12 Months 21.621891
Profit Margins -2.36948
Quick Ratio 10.55
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 2.11111
Region US
Regular Market Change -2.5
Regular Market Change Percent -3.0303
Regular Market Day High 80.9899
Regular Market Day Low 77.7
Regular Market Day Range 77.7 - 80.9899
Regular Market Open 80.131
Regular Market Previous Close 82.5
Regular Market Price 80.0
Regular Market Time 1,787,947,201
Regular Market Volume 658,441
Return On Assets -0.12031999
Return On Equity -0.16124001
Revenue Growth 0.257
Revenue Per Share 4.114
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 44,666,234
Shares Percent Shares Out 0.1826
Shares Short 8,155,446
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 7,733,785
Short Name GRAIL, Inc.
Short Percent Of Float 0.1855
Short Ratio 12.78
Source Interval 15
State CA
Symbol GRAL
Target High Price 88.0
Target Low Price 60.0
Target Mean Price 72.375
Target Median Price 74.5
Total Cash 861,609,024
Total Cash Per Share 19.29
Total Debt 91,309,000
Total Revenue 165,263,008
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -9.4
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 73.28693
Two Hundred Day Average Change 6.7130737
Two Hundred Day Average Change Percent 0.09159988
Type Disp Equity
Volume 658,441
Website https://grail.com
Zip 94,025